Opportunity Information: Apply for RFA AR 21 003
The NIAMS Skin Biology and Diseases Resource-based Centers program (P30; Clinical Trial Not Allowed) is a National Institutes of Health funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intended to strengthen and expand shared research infrastructure for investigators working in skin biology and skin disease areas aligned with the NIAMS mission. Rather than funding stand-alone research projects, this mechanism supports a centralized, resource-based "center" model that offers shared facilities, services, and other research-enabling resources to a community of researchers. The main idea is to make ongoing, independently funded basic, translational, and clinical research faster, more efficient, and more effective by reducing duplication, improving access to specialized capabilities, and encouraging collaboration. A related goal is to create an environment that helps spark new NIAMS-relevant research by lowering barriers to entry for new approaches, new investigators, and cross-disciplinary teams.
The center is expected to function as a hub of critical capabilities that multiple investigators can use, such as shared cores, specialized instrumentation, methodological expertise, data resources, biorepositories, or other services that are difficult for individual labs to maintain on their own. By consolidating these resources and coordinating access, the program aims to accelerate progress in skin biology and disease research broadly, improve the quality and consistency of research outputs, and enhance the overall return on investment for existing NIH- and other independently funded projects that rely on these capabilities. Because it is a P30 resource-based center, the emphasis is on infrastructure and service to an investigator group, not on running clinical trials; clinical trials are explicitly not allowed under this opportunity.
Eligible applicants span a wide range of U.S.-based organizations and government entities. These include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations (other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The opportunity also explicitly highlights several categories of eligible or encouraged applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions.
Foreign eligibility is limited. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. Non-domestic components of U.S. organizations are also not eligible to apply. However, "foreign components" as defined in the NIH Grants Policy Statement are allowed, meaning a U.S. applicant may include certain well-justified international elements within the project structure when permitted by NIH policy, even though the primary applicant must be domestic.
Administratively, this is a discretionary grant program under NIH, categorized under health, with CFDA number 93.846. The funding opportunity title is "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)" and the funding opportunity number is RFA-AR-21-003. The original closing date listed for the opportunity was August 11, 2020, and the posting creation date was March 6, 2020. The award ceiling and expected number of awards were not specified in the provided source data.Apply for RFA AR 21 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
- This funding opportunity was created on 2020-03-06.
- Applicants must submit their applications by 2020-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the NIAMS Skin Biology and Diseases Resource-based Centers program?
It is a National Institutes of Health (NIH) funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support resource-based centers focused on skin biology and skin diseases that align with the NIAMS mission.
What activity code or grant mechanism does this opportunity use?
This opportunity uses the P30 mechanism, which is designed to support resource-based centers (infrastructure and shared research resources) rather than stand-alone research projects.
Are clinical trials allowed under this funding opportunity?
No. The funding opportunity is explicitly designated as "Clinical Trial Not Allowed."
What is the main purpose of funding a resource-based center instead of individual research projects?
The purpose is to strengthen and expand shared research infrastructure that multiple investigators can use, making ongoing, independently funded basic, translational, and clinical research faster, more efficient, and more effective by reducing duplication, improving access to specialized capabilities, and encouraging collaboration.
What types of research does the program aim to support?
The center is intended to enable and accelerate independently funded basic, translational, and clinical research in skin biology and skin diseases that are relevant to the NIAMS mission, by providing shared resources and capabilities.
What does "resource-based center" mean in practice?
It means a centralized "hub" that provides shared facilities, services, and other research-enabling resources to a community of researchers, rather than operating as a single lab or funding a single scientific project.
What kinds of shared resources or capabilities might a P30 center provide?
Examples described include shared cores, specialized instrumentation, methodological expertise, data resources, biorepositories, and other services that are difficult for individual labs to maintain on their own.
Who is expected to benefit from the center?
A community of investigators working in skin biology and skin disease areas aligned with the NIAMS mission, particularly those already supported by NIH and other independent funding sources that rely on specialized shared capabilities.
How does this program aim to improve research efficiency?
By consolidating resources and coordinating access so multiple investigators can use shared capabilities, reducing duplication of expensive infrastructure, improving access to specialized tools and expertise, and promoting collaboration.
What is meant by improving "return on investment" for existing research projects?
The program is intended to enhance the value and impact of existing NIH- and other independently funded projects by providing shared infrastructure and services that improve quality, consistency, and efficiency for research that depends on those capabilities.
Does this program aim to support new investigators or new research directions?
Yes. A stated goal is to create an environment that can spark new NIAMS-relevant research by lowering barriers to entry for new approaches, new investigators, and cross-disciplinary teams.
Is the focus of the P30 award on generating new research findings directly?
The emphasis is on infrastructure and service to a group of investigators. The center is designed to enable and accelerate research that is funded through other mechanisms, rather than operating as a stand-alone research project.
Who can apply for this opportunity?
Eligible applicants include a broad set of U.S.-based organizations and government entities, including various levels of government, institutions of higher education (public/state-controlled and private), nonprofits (with or without 501(c)(3) status, other than institutions of higher education), for-profit organizations (other than small businesses), and small businesses.
Are institutions of higher education eligible?
Yes. Both public and state-controlled institutions of higher education and private institutions of higher education are listed as eligible.
Are nonprofits eligible to apply?
Yes. Nonprofits with 501(c)(3) status (other than institutions of higher education) and nonprofits without 501(c)(3) status (other than institutions of higher education) are listed as eligible.
Are for-profit entities eligible to apply?
Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also listed as eligible.
Which government entities are eligible applicants?
Eligible government applicants include state governments; county governments; city or township governments; special district governments; independent school districts; and eligible federal agencies.
Are tribal entities eligible to apply?
Yes. Federally recognized Native American tribal governments are listed as eligible, along with Native American tribal organizations (other than federally recognized tribal governments). The opportunity also highlights Indian/Native American tribal governments other than federally recognized entities.
Are U.S. territories eligible?
Yes. U.S. territories or possessions are explicitly highlighted among eligible or encouraged applicant types.
Are faith-based or community-based organizations eligible?
They are explicitly highlighted among eligible or encouraged applicant types in the opportunity information provided.
Are non-U.S. (foreign) organizations eligible to apply as the applicant?
No. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the applicant organization.
Can a non-domestic component of a U.S. organization apply?
No. Non-domestic components of U.S. organizations are not eligible to apply.
Are any international elements permitted in a project if the applicant is U.S.-based?
Yes. "Foreign components" (as defined in the NIH Grants Policy Statement) are allowed, meaning a U.S. applicant may include well-justified international elements within the project structure when permitted by NIH policy, even though the primary applicant must be domestic.
What is the funding opportunity number?
The funding opportunity number is RFA-AR-21-003.
What is the official title of the funding opportunity?
The title is "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)."
Which NIH institute is offering this opportunity?
The opportunity is offered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which is part of the National Institutes of Health (NIH).
What is the program type and broad category?
It is a discretionary grant program under NIH and is categorized under health.
What is the CFDA number listed for this opportunity?
The CFDA number provided is 93.846.
When was the opportunity posted and when was the original closing date?
The posting creation date provided is March 6, 2020, and the original closing date listed was August 11, 2020.
Is the award ceiling specified?
No. The award ceiling was not specified in the provided source information.
Is the expected number of awards specified?
No. The expected number of awards was not specified in the provided source information.
Browse more opportunities from the same category: Health
Next opportunity: Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Previous opportunity: U.S. Governance Videos
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AR 21 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AR 21 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 016 Funding Number: RFA AI 20 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) Apply for PAR 20 127 Funding Number: PAR 20 127 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) Apply for PAS 20 121 Funding Number: PAS 20 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 010 Funding Number: RFA AI 20 010 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 20 015 Funding Number: RFA AI 20 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed) Apply for RFA AR 21 004 Funding Number: RFA AR 21 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) Apply for RFA AG 21 019 Funding Number: RFA AG 21 019 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) Apply for RFA AI 20 028 Funding Number: RFA AI 20 028 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) Apply for RFA DE 20 006 Funding Number: RFA DE 20 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Apply for PAR 20 139 Funding Number: PAR 20 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) Apply for RFA DE 20 007 Funding Number: RFA DE 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) Apply for PAR 20 138 Funding Number: PAR 20 138 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) Apply for PA 20 141 Funding Number: PA 20 141 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) Apply for RFA HG 20 015 Funding Number: RFA HG 20 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) Apply for RFA HG 20 014 Funding Number: RFA HG 20 014 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) Apply for RFA HG 20 016 Funding Number: RFA HG 20 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) Apply for RFA AI 20 007 Funding Number: RFA AI 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Centers (U01 Clinical Trial Not Allowed) Apply for RFA HG 20 001 Funding Number: RFA HG 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed) Apply for RFA DC 20 001 Funding Number: RFA DC 20 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 20 024 Funding Number: RFA AI 20 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AR 21 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.